Top Story

FDA expands approval of Adcetris for advanced classical Hodgkin Lymphoma

March 20, 2018

Racial minorities with hematologic cancers receive more aggressive end-of-life care

March 20, 2018
Patients with hematologic malignancies received more aggressive
Meeting News

Chemotherapy may limit ability to develop effective CAR T cells

March 16, 2018
Pediatric patients with solid tumors may have poor-quality T cells compared with patients with leukemia, and certain prior chemotherapies significantly affected the…
Meeting NewsVideo

VIDEO: CAR T cells effective for non-Hodgkin lymphoma

March 13, 2018
NEW YORK — In this video commentary from HemOnc Today New York, Stephen J. Schuster, MD, discusses treatment with CD19-directed chimeric antigen receptor T cells…
More Headlines »

Applying Advances with Checkpoint Inhibitors in Thoracic Oncology

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer-related deaths worldwide. It is estimated that 222,500 new cases of lung…
More »

Baseball Hall of Famer Mike Schmidt promotes sun protection, skin cancer awareness

September 28, 2017
More »
Resource Centers
HemOnc Today New York

HemOnc Today New York


Immune Checkpoint Inhibitors in Advanced Melanoma: What You May Have Missed in Madrid

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incidence of melanoma in the United States continues to rise as demonstrated by the Surveillance, Epidemiology and…
More »